Steroid Eye Implants and the Trade-Off: Higher Eye Pressure and Faster Cataracts
Steroid Eye Implants: The Trade-Off in Plain Terms
Steroid eye implants are very good at calming inflammation and swelling at the back of the eye, but they come with two well-known trade-offs: they can raise the pressure inside your eye, and they speed up cataracts. Both are common enough that your doctor plans for them, yet both are usually manageable: raised pressure is most often controlled with drops, and cataracts are fixed with routine surgery5. The single most useful thing you can do is keep every eye-pressure check, because a rising pressure usually causes no symptoms at all.
Here is the point that protects your sight the most. Steroid-induced high eye pressure is usually completely silent, causing no pain or visual change until damage is already done, which is exactly why scheduled pressure checks matter5. You cannot feel a dangerous pressure, so do not wait to feel unwell. Going to your monitoring visits, even when your eye feels perfectly fine, is what lets your doctor catch and treat a rise before it can harm the optic nerve.
Before agreeing to a steroid implant, ask two questions: do I still have my natural lens, and what is my eye pressure now. If you have already had cataract surgery, the cataract trade-off does not apply to you, and if you tend to get pressure spikes on steroids, your doctor may watch you more closely or choose a different treatment8. Agree on a monitoring schedule at the same visit, so you know when your pressure will be checked.
What Steroid Eye Implants Are and Why They Are Used
A steroid eye implant is a tiny pellet placed inside the eye that slowly releases a corticosteroid to calm inflammation. The main ones are the dexamethasone implant (Ozurdex) and the fluocinolone acetonide implants (Iluvien, Yutiq, and Retisert), which differ mainly in dose and how long they last1. The dexamethasone implant dissolves over months, while the fluocinolone implants can last around three years. All share the same two trade-offs.
These implants are used for stubborn swelling and inflammation at the back of the eye. Depending on the implant, they treat diabetic macular edema (swelling of the central retina from diabetes), swelling after a retinal vein blockage, and chronic non-infectious uveitis1. They are usually chosen when drops or injections have not controlled the problem, or when a longer-lasting treatment would help.
Steroids are strong anti-inflammatory medicines, but taken as pills for a long time they cause whole-body side effects. Placing a small amount right inside the eye concentrates the benefit where it is needed. A local implant delivers steady anti-inflammatory treatment to the retina while keeping the dose to the rest of the body low3. The eye-pressure and cataract effects are the price of putting a steroid where it works best.
Trade-Off Number One: Higher Eye Pressure
A pressure rise is common but usually treatable with drops. The chance depends on the implant. With the dexamethasone implant, about 42 of every 100 people needed pressure-lowering drops at some point, while only about 1 of 100 needed surgery for pressure1. With the fluocinolone implants, roughly 38 to 43 of 100 needed pressure drops, and few needed surgery, about 5 of 100 for one implant and about 2 of 100 for another2. So most pressure rises are handled with eye drops, not an operation.
This is the part that catches people out. A steroid-driven pressure rise usually produces no symptoms at all, even when the pressure is quite high, so you cannot rely on how your eye feels5. Left unnoticed, high pressure can slowly damage the optic nerve, which is what glaucoma is. The good news is that it is easy to measure and easy to treat once found, so keeping your scheduled pressure checks turns a silent risk into a managed one.
If your pressure goes up, treatment usually starts simply. Pressure-lowering eye drops are the first step and control the rise in most people, with laser or surgery reserved for the minority whose pressure cannot be controlled with drops5. In the implant studies, the share needing pressure surgery was small for most implants. Once the steroid wears off, a pressure rise often eases too, though your doctor keeps watching to be sure.
Trade-Off Number Two: Faster Cataracts
If you still have your natural lens, expect a cataract to form or speed up. With the dexamethasone implant, about 68 of every 100 people with a natural lens developed a cataract and about 61 of 100 had cataract surgery1. With the longer-lasting fluocinolone implants the rates are higher still, with cataract surgery in around 80 of 100 natural-lens eyes for one implant, and nearly all natural-lens eyes affected with the highest-dose implant2. This is expected with any long-acting eye steroid.
A cataract sounds alarming, but it is one of the most treatable problems in all of medicine. Steroid-related cataracts are removed with routine cataract surgery, the same quick, highly successful operation used for age-related cataracts1. People who have already had cataract surgery avoid this trade-off entirely, which is one reason a steroid implant can be an easier choice for them8. So the cataract risk is real but rarely a reason on its own to refuse a needed implant.
How the Trade-Off Differs by Implant, and Who Is Most Affected
The trade-off is bigger for the stronger, longer-lasting implants. The figures below are drawn from each implant's FDA information1234.
| Implant | Needed pressure drops | Cataract in natural-lens eyes |
|---|---|---|
| Ozurdex (dexamethasone, months) | About 42 in 100 | About 68 in 100 |
| Yutiq (fluocinolone, ~3 years) | About 43 in 100 | About 56 in 100 |
| Iluvien (fluocinolone, ~3 years) | About 38 in 100 | About 82 in 100 |
| Retisert (fluocinolone, highest dose) | About 77 in 100 | Nearly all |
The highest-dose, longest-lasting implant (Retisert) carries the biggest trade-off, with most people needing pressure drops and a sizable share, about 37 of 100, needing pressure surgery4. Shorter or lower-dose implants tend to be gentler.
Some people react to steroids more than others. Among steroid users, roughly 5 of every 100 have a large pressure rise and about a third have a smaller one, while most have none, and the risk is higher if you have glaucoma, a family history of it, are very short-sighted, or are very young5. Because of this, some steroid implants are used cautiously, or avoided, in people with glaucoma or a known steroid-pressure reaction8. Tell your doctor if you have ever had a pressure rise on steroid drops.
The cataract trade-off only affects natural-lens eyes. People who have already had cataract surgery and have an artificial lens do not face this risk, and may be better candidates for a steroid implant for that reason8. If you still have your natural lens, it does not rule out an implant; it simply means a cataract may be part of the plan, and it can be dealt with when the time comes.
When to See a Doctor
One pressure problem is a true emergency and feels very different from the silent kind. Go to an emergency room or an eye doctor immediately if you have:
- Sudden severe eye pain or a bad headache around the eye
- Nausea or vomiting with eye pain, or halos and rainbow rings around lights
- Sudden blurring or loss of vision, or a very red, painful eye
These can signal a sudden, dangerous pressure spike (an angle-closure attack), which is a medical emergency that needs treatment right away to save vision7.
The everyday, steroid-related pressure rise is the opposite of that emergency: it is silent. Because you cannot feel a gradually rising pressure, the only way to catch it is a measured check, so keeping your scheduled visits is essential even when nothing feels wrong5. If you miss checks because your eye feels fine, a silent rise can go untreated. Treat your pressure appointments as non-negotiable while you have a steroid implant.
Some changes are not emergencies but still deserve a prompt call to your eye doctor:
- Vision that is gradually getting blurrier or dimmer, which may be a cataract forming
- Glare, faded colors, or trouble seeing at night
- Any concern about your drops or your monitoring schedule
These usually reflect the expected, treatable trade-offs rather than an emergency, and your doctor can confirm and plan the next step.
Steroid implants are managed by an ophthalmologist, often a retina or uveitis specialist, who monitors your pressure and lens. For the sudden, painful, emergency symptoms above, go to an emergency room or call your eye doctor immediately. For gradual changes, contact your eye specialist within a few days.
Common Questions About Steroid Eye Implants
It can raise your eye pressure and speed up a cataract, and these are the two main trade-offs. A meaningful share of people need pressure-lowering drops, and most people with a natural lens eventually develop a cataract1. The reassuring part is that both are usually managed: pressure with drops and monitoring, cataract with routine surgery. High pressure only becomes glaucoma if it goes unnoticed and untreated, which is why your pressure checks matter so much.
If you still have your natural lens, it is fairly likely over the life of a long-acting implant. Cataract surgery was needed in roughly 61 of 100 people with the dexamethasone implant and around 80 of 100 with a long-acting fluocinolone implant1. That sounds high, but cataract surgery is quick and very successful, so it is a manageable step rather than a loss of vision. If you have already had cataract surgery, this does not apply to you.
Common, but usually controllable. Depending on the implant, roughly 38 to 43 of every 100 people needed pressure-lowering drops, and with the highest-dose implant about 77 of 100 did1. Most of these rises are handled with drops alone. Only a small share, a few in 100 for most implants, needed surgery to control pressure. Your doctor checks your pressure regularly so any rise is caught early.
Usually not, if it is caught and treated. Raised pressure is typically controlled with drops, and it often eases once the steroid wears off, though your doctor keeps monitoring to be sure5. Permanent harm comes only when a high pressure goes unnoticed long enough to damage the optic nerve. That is avoidable with regular checks, which is the whole reason monitoring is built into your care.
Usually no, and that is the key danger. Steroid-induced high pressure is almost always silent, with no pain or visual change until damage has occurred5. The exception is a sudden angle-closure attack, which is very painful with headache, nausea, and halos, and is a same-day emergency. But the ordinary steroid pressure rise gives no warning, so you cannot skip pressure checks just because your eye feels fine.
No. Once you have an artificial lens from cataract surgery, a steroid implant cannot give you a cataract, so that trade-off is gone for you8. You still need your eye-pressure watched, because the pressure trade-off applies to everyone with a steroid implant. But being past cataract surgery removes one of the two main downsides and can make an implant an easier choice.
More Questions, and Where These Answers Come From
Generally, the shorter-acting and lower-dose implants are gentler. The highest-dose, longest-lasting implant carries the biggest trade-off, with most people needing pressure drops and about 37 of 100 needing pressure surgery, while the dexamethasone implant, which lasts only months, tends to be milder4. In everyday practice, real-world rates are often somewhat lower than in the original trials6. The best choice balances how long your eye needs treatment against how much trade-off you can accept.
Often, yes, when it protects sight the alternatives cannot. The point of the implant is to control inflammation or swelling that itself threatens your vision. Because raised pressure is usually controlled with drops and cataracts are fixable with surgery, the trade-offs are generally manageable side effects rather than reasons to lose vision5. It is a genuine decision to make with your doctor, weighing the benefit for your specific condition against these known, treatable trade-offs.
Go the same day for sudden severe eye pain, a bad headache with nausea or vomiting, halos or rainbows around lights, a very red painful eye, or a sudden drop in vision. These suggest a sudden dangerous pressure spike or another acute problem and need emergency treatment to protect sight7. This is different from the silent, gradual pressure rise, which has no symptoms and is caught at your scheduled checks. When in doubt about severe pain or sudden vision loss, treat it as an emergency.
These questions help you plan around the trade-offs:
- Do I still have my natural lens, and how likely am I to need cataract surgery?
- What is my eye pressure now, and have I ever reacted to steroids with a pressure rise?
- How often will my eye pressure be checked while I have the implant?
- Given my eyes, which implant has the best balance of benefit and trade-off for me?
- What exact symptoms should send me to the emergency room the same day?
- OZURDEX (dexamethasone intravitreal implant) 0.7 mg Prescribing Information. FDA label via DailyMed. Eye-pressure and cataract rates; treated conditions.
- ILUVIEN (fluocinolone acetonide intravitreal implant) 0.19 mg Prescribing Information. FDA label via DailyMed. Pressure-medication, pressure-surgery, and cataract rates.
- YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg Prescribing Information. FDA label via DailyMed. Local steroid delivery; eye-pressure and cataract rates.
- RETISERT (fluocinolone acetonide intravitreal implant) 0.59 mg Prescribing Information. FDA label via DailyMed. Highest-dose implant; pressure surgery in about 37% and cataract in nearly all natural-lens eyes.
- American Academy of Ophthalmology (EyeNet). Management of Steroid-Induced Glaucoma. Usually symptomless nature, steroid-responder rates, and drops-first management.
- Fluocinolone acetonide vitreous insert: systematic review with meta-analysis of real-world experience. Scientific Reports (2021). Real-world pressure and cataract rates.
- Glaucoma Research Foundation. Angle-Closure Glaucoma. Emergency symptoms of an acute pressure spike.
- Safety and Efficacy of the Dexamethasone Intravitreal Implant First-Line versus Second-Line in Diabetic Macular Edema (2023). Pseudophakic patients as candidates; glaucoma cautions.